All Stories

  1. High-density lipoprotein protects vascular endothelial cells from indoxyl sulfate insults through its antioxidant ability
  2. Abstract 11795: CXCL5 Inhibition Recovers Neovascularization in Diabetes Mellitus
  3. Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease
  4. Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
  5. CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
  6. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease
  7. Abstract 9464: Adipocyte-Derived Fatty-Acid-Binding Protein 4 Impairs Human Dermal Microvascular Endothelial Cells Under Hypoxia Insults - A Mechanistic Clue to Impaired Wound Healing in Obesity
  8. CCL4 Deletion Accelerates Wound Healing by Improving Endothelial Cell Functions in Diabetes Mellitus
  9. Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy
  10. Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection
  11. Abstract 8907: Fatty-Acid-Binding Protein 3 as a Novel Inducer of Adhesion Molecules in Atherosclerosis
  12. Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus
  13. Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy
  14. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
  15. Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis
  16. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation
  17. The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
  18. Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency
  19. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure
  20. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
  21. Inhibition of macrophage inflammatory protein-1β improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes
  22. Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study
  23. MP482IVABRADINE IN ANGIOGENESS OF DIABETIC MICE
  24. Risk of Febuxostat-Associated Myopathy in Patients with CKD
  25. Usefulness of the CHADS2 Score for Prognostic Stratification in Patients With Coronary Artery Disease Having Coronary Artery Bypass Grafting
  26. Effect of dyad training on medical students’ cardiopulmonary resuscitation performance
  27. Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism
  28. Clinical and Genetic Factors for Thiazide-Induced Hyponatremia
  29. Indicators associated with coronary atherosclerosis in metabolic syndrome
  30. Prognostic Value of Circulating Adipokine Levels and Expressions of Adipokines in the Myocardium of Patients With Chronic Heart Failure
  31. L-006 GENOME-WIDE SCAN FOR YOUNG-ONSET HYPERTENSION IN HAN CHINESE IN TAIWAN
  32. Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension
  33. EFFECT OF ANNUAL INFLUENZA VACCINATION ON MORTALITY AND HOSPITALIZATION IN PATIENTS WITH CHRONIC HEART DISEASE
  34. Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke
  35. Estimation of central systolic blood pressure using an oscillometric blood pressure monitor
  36. S22-3 Biomarkers for Advanced Risk Stratification
  37. Predictors of inexplicable coronary artery spasm during coronary angiography in patients with stable angina — The role of intravascular oxidative stress
  38. S4-1 MEDICAL THERAPY FOR ACUTE MYOCARDIAL INFARCTION
  39. S37-4 ADHESION MOLECULES IN CONGESTIVE HEART FAILURE
  40. Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure
  41. Multimarker Approach to Risk Stratification Among Patients with Advanced Chronic Heart Failure
  42. Antiphospholipid Syndrome Presenting as Intracardiac Thrombus With Pulmonary Embolism
  43. Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium
  44. The “ribbon sign” of aortic coarctation
  45. Clinical characteristics of young-onset hypertension—implications for different genders
  46. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure
  47. Atherosclerotic Left Main Coronary Artery Aneurysm?Case Reports
  48. P4-03 Modulation of the gene expression profile by Ginkgo Biloba in TNF-α-treated human aortic endothelial cells
  49. Differentiating Syndrome X from Coronary Artery Disease by Treadmill Exercise Test in Patients with Chest Pain and Exercise-Induced Myocardial Ischemia